UNSW Sydney Professor Guy Marks and Garvan Institute of Medical Research Professor Susan Clark have been recognised for outstanding contributions to health and medical research.
UNSW Sydney researchers have received funding from the Australian Government for COVID-19 projects, including the development of new antibody drugs and to repurpose medications.
Breakthrough cellular genomics technology has allowed Garvan and UNSW Sydney researchers to reveal genetic mutations causing rogue behaviour in the cells at the root of autoimmune disease.
UNSW researchers have taken out five NSW Premier’s Prizes for Science & Engineering for works spanning from ecosystem conservation to pancreatic cancer treatment.
Researchers from Sydney's Garvan Institute and the UK have developed a glow-in-the-dark 'biosensor mouse' that offers a real-time readout of the rapidly changing "skeleton" within cells.
An international study has provided compelling evidence that we inherit more than a DNA blueprint from our mothers and fathers – we also inherit vital instructions on how to use this blueprint.
In cancer, immune cells infiltrate tumours – but it hasn’t been known which immune cells exit the tumour or where they go next.
A two-step approach has had promising results in the treatment of pancreatic cancer, which has a dismal five-year survival rate of just 7%.
Garvan Institute immunologist UNSW Conjoint Professor Shane Grey and collaborators have been awarded $3.3 million to continue innovative research into islet transplantation therapy as a cure for type I diabetes.
When obese people diet, they often find it virtually impossible to lose weight. Now researchers have found the brain circuitry behind the phenomenon.